1. Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: a qualitative systematic review.
- Author
-
Bourgier C, Aimard L, Bodez V, Bollet MA, Cutuli B, Franck D, Hennequin C, Kirova YM, and Azria D
- Subjects
- Axilla, Breast Neoplasms pathology, Breast Neoplasms surgery, Female, Humans, Lymphatic Metastasis, Mastectomy, Segmental, Neoplasm Invasiveness, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Adjuvant, Tumor Burden, Breast Neoplasms radiotherapy, Lymph Nodes pathology
- Abstract
Purpose: To actualize and to detail guidelines used in technical radiotherapy and indications for innovative radiation technologies in early axillary node negative breast cancer (BC)., Methods: Dosimetric and treatment planning studies, phase II and III trials, systematic reviews and retrospective studies were all searched (Medline(®) database). Their quality and clinical relevance were also checked against validated checklists. A level of evidence was associated for each result., Results: A total of 75 references were included. Adjuvant BC radiotherapy (50Gy/25 fractions/5 weeks followed by a tumor boost of 16Gy/8 fractions) is still the standard of care. Overall treatment time could be shortened for patients who present with low local relapse risk BC by using either hypofractionated whole breast irradiation; or accelerated partial breast irradiation. BC IMRT is not used in current practice., Conclusion: Our group aimed to provide guidelines for technical and clinical applications of innovative BC radiation technologies., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF